Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Joshinkai Medical Corporation is a leading Japanese healthcare organization dedicated to clinical research and the advancement of drug development. The corporation operates two primary clinical trial centers: the OCROM Clinic in Osaka and the ToCROM Clinic in Tokyo, both of which specialize in Phase 1 and early-phase clinical studies. These facilities provide high-quality environments for testing new pharmaceuticals in both healthy volunteers and specific patient populations. Joshinkai is a key partner for domestic and international pharmaceutical companies seeking to conduct clinical trials in Japan, offering extensive expertise in regulatory compliance and trial management. The organization is recognized for its long-standing history in the Japanese clinical trial industry, having supported the development of numerous drugs now on the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Corporation Joshinkai.